Next Science study publication announcement

Next Science Limited (ASX: $NXS) has announced the publication of a study demonstrating the efficacy of BLASTX™ in conjunction with negative pressure wound therapy (NPWT) for the treatment of pressure ulcers. The study, titled 'A Diagnostic-Driven Prospective Clinical Study Evaluating the Combination of an Antibiofilm Agent and Negative Pressure Wound Therapy' by Dr Thomas E. Serena MD et al., has been published in Diagnostics, an international peer-reviewed journal.

Executive Commentary on Study Publication

The study by leading wound care specialist Dr Thomas Serena shows that the use of BLASTX™ should be considered when treating pressure ulcers with NPWT. The results have been through a peer review process and their publication in Diagnostics, an international journal adds to the growing clinical evidence highlighting the efficacy of BLASTX™ in improving health outcomes for patients. We will continue to work closely with the medical community to conduct clinical research that further investigates the effectiveness of Next Science's products.

Summary of Next Science Study Publication

Next Science Limited (ASX: $NXS) has published a study demonstrating the efficacy of BLASTX™ in conjunction with negative pressure wound therapy (NPWT) for the treatment of pressure ulcers. The study, conducted by Dr Thomas E. Serena MD et al., found that the combination of BLASTX™ and NPWT reduced bacterial levels and improved wound healing in recalcitrant pressure ulcers. The publication in Diagnostics, an international peer-reviewed journal, adds to the growing clinical evidence highlighting the efficacy of BLASTX™ in improving health outcomes for patients. Next Science aims to continue conducting clinical research to further investigate the effectiveness of its products in improving health outcomes for patients.